Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: The potential implications for clinical practice

JACC: Cardiovascular Interventions

Volumn 6, Issue 5, 2013, Pages 523-532

  Farooq, Vasim ^a   Serruys, Patrick W ^a   Heo, Jung Ho ^a   Gogas, Bill D ^a   Onuma, Yoshinobu ^a   Perkins, Laura E ^b   Diletti, Roberto ^a   Radu, Maria D ^a   Räber, Lorenz ^a   Bourantas, Christos V ^a   Zhang, Yaojun ^a   Van Remortel, Eric ^c   Pawar, Ravindra ^c   Rapoza, Richard J ^b   Powers, Jennifer C ^b   Van Beusekom, Heleen M M ^a   Garcìa Garcìa, Hector M ^a   Virmani, Renu ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ABBOTT VASCULAR   (United States)

^c CARDIALYSIS   (Netherlands)

^d CVPATH INSTITUTE   (United States)

Author keywords

biodegradable polymer; drug eluting stent; imaging; overlapping stents; pathology

Indexed keywords

EVEROLIMUS;

ANIMAL TISSUE; ARTICLE; BIODEGRADABLE IMPLANT; BIORESORBABLE VASCULAR SCAFFOLD; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; HISTOLOGY; INFLAMMATION; INTERMETHOD COMPARISON; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ABSORBABLE IMPLANTS; ANIMALS; CARDIOVASCULAR AGENTS; CORONARY VESSELS; DRUG-ELUTING STENTS; MODELS, ANIMAL; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; SIROLIMUS; SWINE; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84877951577     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2012.12.131     Document Type: Article

References (28)

1. P.W. Serruys, Y. Onuma, J.A. Ormiston Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes Circulation 122 2010 2301 2312
2. Y. Onuma, P.W. Serruys, L.E. Perkins Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial Circulation 122 2010 2288 2300
3. P.W. Serruys, J.A. Ormiston, Y. Onuma A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 2009 897 910
4. J.A. Ormiston, P.W. Serruys, E. Regar A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial Lancet 371 2008 899 907
5. P.W. Serruys, H.M. Garcia-Garcia, Y. Onuma From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J 33 2012 16 25b
6. T. Palmerini, G. Biondi-Zoccai, D. Della Riva Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
7. A.V. Finn, F.D. Kolodgie, J. Harnek Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents Circulation 112 2005 270 278
8. G.J. Wilson, J.E. Polovick, B.A. Huibregtse, B.C. Poff Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model Cardiovasc Res 76 2007 361 372
9. L.E.L. Perkins, K.H. Boeke-Purkis, Q. Wang, S.K. Stringer, L.A. Coleman XIENCE Veverolimus-eluting coronary stent system: a preclinical assessment J Interv Cardiol 22 2009 S28 S40
10. R. Virmani, F.D. Kolodgie, A. Farb, A. Lafont Drug eluting stents: are human and animal studies comparable? Heart 89 2003 133 138
11. J.L. Gutierrez-Chico, R.J. van Geuns, E. Regar Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial Eur Heart J 32 2011 2454 2463
12. J.L. Gutierrez-Chico, E. Regar, E. Nuesch Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography Circulation 124 2011 612 623
13. V. Farooq, Y. Onuma, M. Radu Optical coherence tomography (OCT) of overlapping bioresorbable scaffolds: from benchwork to clinical application EuroIntervention 7 2011 386 399
14. P.W. Serruys, Y. Onuma, D. Dudek Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes J Am Coll Cardiol 58 2011 1578 1588
15. P.W. Serruys, G. Sianos, A. Abizaid The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES) J Am Coll Cardiol 46 2005 253 260
16. V. Farooq, B.D. Gogas, P.W. Serruys Restenosis: delineating the numerous causes of drug-eluting stent restenosis Circ Cardiovasc Interv 4 2011 195 205
17. A. Kastrati, J. Mehilli, J. Dirschinger Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial Circulation 103 2001 2816 2821
18. J. Pache, A. Kastrati, J. Mehilli Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial J Am Coll Cardiol 41 2003 1283 1288
19. G. Biondi-Zoccai, C. Moretti, A. Abbate, I. Sheiban Percutaneous coronary intervention for small vessel coronary artery disease Cardiovasc Revasc Med 11 2010 189 198
20. O. Frobert, B. Lagerqvist, J. Carlsson, J. Lindback, U. Stenestrand, S.K. James Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry) J Am Coll Cardiol 53 2009 1660 1667
21. M. Joner, G. Nakazawa, A.V. Finn Endothelial cell recovery between comparator polymer-based drug-eluting stents J Am Coll Cardiol 52 2008 333 342
22. K.C. Koskinas, Y.S. Chatzizisis, A.P. Antoniadis, G.D. Giannoglou Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation J Am Coll Cardiol 59 2012 1337 1349
23. J.J. Wentzel, R. Krams, J.C. Schuurbiers Relationship between neointimal thickness and shear stress after Wallstent implantation in human coronary arteries Circulation 103 2001 1740 1745
24. J. Gomez-Lara, S. Brugaletta, V. Farooq Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography J Am Coll Cardiol Intv 4 2011 1271 1280
25. J. Gomez-Lara, S. Brugaletta, V. Farooq Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up J Am Coll Cardiol Intv 4 2011 789 799
26. M.W. Liu, G.S. Roubin, S.B. King 3rd Restenosis after coronary angioplasty Potential biologic determinants and role of intimal hyperplasia Circulation 79 1989 1374 1387
27. S. Tahara, H.G. Bezerra, V. Sirbu Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial Heart 96 2010 1574 1578
28. S. Brugaletta, J.H. Heo, H.M. Garcia-Garcia Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? Eur Heart J 33 2012 1325 1333